Julie Gerberding at the 2025 LaMontagne Lecture

Apr

2025

2:00 pm

In Person (view details)

Featured Speaker(s): Julie Gerberding

Cost: Free

Dr. Julie Gerberding, MD, MPH, CEO of the Foundation for the National Institutes of Health, will be the keynote speaker at the 2025 John Ring LaMontagne Annual Keynote Lecture and Symposium.

Description

Dr. Gerberding joined the FNIH as CEO in 2022. Previously she served as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck & Co., Inc. In 2002 she became the first woman to head the U.S. Centers for Disease Control and Prevention (CDC), and during her tenure from 2002-2009, she responded to dozens of public health emergencies including avian influenza, SARS-CoV-1, food poisoning outbreaks and natural disasters. The title of her presentation is “Beyond One-Size-Fits-All: Rebuilding Trust and Advancing Precision Public Health in the AI Era.”

A world-renowned public health and biosecurity expert, Dr. Gerberding has received several awards, including the Department of Health and Human Services Distinguished Service Award and the United States Public Health Service Surgeon General’s Medallion. She has been included in Forbes Magazine’s 100 Most Powerful Women in the World and Time Magazine’s 100 Most Influential People in the World.

Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University and a Master of Public Health at the University of California, Berkeley. She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco, where she is currently an Adjunct Associate Professor of Medicine.

In addition, her board service includes Mayo Clinic, Case Western Reserve University, McKesson, National Health Council, Research!America, and several leadership councils at the National Academies of Science, Engineering, and Medicine, among others. She also co-chairs the Center for Strategic and International Studies Bipartisan Alliance for Global Health Security. She is deeply committed to ensuring that our expanding scientific capabilities are translated in sustainable improvements in health, well-being, and biosecurity around the world.